Patent · US Active

ALK kinase inhibitor, and preparation method and uses thereof

US10023593B2 · kind B2 · utility

0Cited by

1References

37Claims

0Family size

Assignee

BEIJING PEARL BIOTECHNOLOGY LIMITED LIABILITY COMPANY · CN

Inventors

Jiaqiang Dong · 浮桥镇, CN
Boyu Zhong · Carmel, US
Hongbin Yuan · Shanghai, CN
Chuan Shih · Carmel, US
Shaosong Chu · 浮桥镇, CN
Deyi Zhang · Carmel, US
Ruihao Zhang · 浮桥镇, CN

Key dates

Filing date	May 29, 2015
Grant date	Jul 17, 2018
Priority date	—
Expiry date	May 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An ALK kinase inhibitor compound as represented by Formula I, pharmaceutical composition containing the compound, and preparation method and use thereof in the preparation of drugs serving as an ALK inhibitor for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.